彰化基督教醫院是彰化基督教醫療財團法人下的總院，屬台灣基督長老教會。1896年由英格蘭長老教會創立，2013年4月3日成立彰化基督教醫療財團法人，彰基是彰化縣唯一的醫學中心。彰化基督教醫療財團法人體系下有7家所屬醫院、1家所屬產後護理之家、3家所屬護理之家。

During the past decade, Changhua Christian Hospital conducted 102 clinical trials. In the 10-year time frame, 102 clinical trials started and 32 clinical trials were completed, i.e. on average, 31.4% percent of trials that started reached the finish line to date. In the past 5 years, 47 clinical trials started and 20 clinical trials were completed. i.e. 42.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Changhua Christian Hospital" #1 sponsor was "Changhua Christian Hospital" with 25 trials, followed by "Bayer" with 8 trials sponsored, "Pfizer" with 8 trials sponsored, "Hoffmann-La Roche" with 7 trials sponsored and "Janssen Research & Development, LLC" with 7 trials sponsored. Other sponsors include 82 different institutions and companies that sponsored additional 70 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Changhua Christian Hospital" #1 collaborator was "Changhua Christian Hospital" with 6 trials as a collaborator, "National Cheng-Kung University Hospital" with 5 trials as a collaborator, "National Taiwan University Hospital" with 5 trials as a collaborator, "Chang Gung Memorial Hospital" with 4 trials as a collaborator and "China Medical University Hospital" with 4 trials as a collaborator. Other collaborators include 71 different institutions and companies that were collaborators in the rest 67 trials.

According to Clinical.Site data, the most researched conditions in "Changhua Christian Hospital" are "Hepatocellular Carcinoma" (4 trials), "Alzheimer's Disease" (3 trials), "Breast Cancer" (3 trials), "Breast Cancer Female" (3 trials) and "Cancer" (3 trials). Many other conditions were trialed in "Changhua Christian Hospital" in a lesser frequency.

Most popular intervention types in "Changhua Christian Hospital" are "Drug" (110 trials), "Biological" (13 trials), "Device" (8 trials), "Other" (8 trials) and "Procedure" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (27 trials), "Carboplatin" (6 trials), "Bevacizumab" (4 trials), "Filgotinib" (4 trials) and "Pembrolizumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Changhua Christian Hospital" are 127 trials for "All" genders, 9 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Changhua Christian Hospital". undefined are not yet recruiting, 29 are recruiting, 17 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 68 completed trials in Changhua Christian Hospital, undefined suspended trials, and 18 terminated clinical trials to date.

Out of the total trials that were conducted in Changhua Christian Hospital, 7 "Phase 1" clinical trials were conducted, 37 "Phase 2" clinical trials and 60 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 12 trials, and there were also 16 trials that are defined as “Not Applicable".

Changhua Christian Hospital has several departments that took part in Clinical trials: "Changhua Christian Hospital; Dept of Surgery" - 13 trials, "Changhua Christian Hospital; Department of Ophthalmology" - 5 trials, "Changhua Christian Hospital; Hematology-Oncology" - 3 trials